Weight Loss

GLP-2 (Tirzepatide) – 3 month subscription

Weekly

Subcutaneous injection

Treatment Category: Weight Loss Available for In-Home Delivery

Next-generation dual-pathway support (GLP-1 + GIP) designed to reduce cravings, enhance metabolic efficiency, and drive meaningful, sustainable weight loss.

Every semaglutide and tirzepatide prescription includes enrollment in our clinician-guided 90-Day Metabolic Health program—weekly checklists, habit scaffolds, exercise & nutrition guidance, and scheduled telehealth check-ins in your Patient Portal.

Prepared by a licensed compounding pharmacy. Certificates of Analysis (COA) are available for each batch upon request. Telemedicine consult required — you’ll be redirected to our secure Patient Portal to complete your medical intake.

Enjoy convenient home delivery across the U.S., excluding residents of Alabama, Kansas, Virginia.

$1,195.00 every 3 months

GLP-2 (Tirzepatide) - 3 month subscription

Snapshot

Formulation: Subcutaneous injection
Typical cadence: Administer weekly for 3 months (details to be provided by your Care Team)
Prescribed by: Licensed medical professional
Processing time: Prescription review: 24–72 hrs • Shipping: 1–3 business days
Storage: Refrigerate; can be at room temp for limited periods
Dosage: Our Care Team will provide personalized dosage & instructions based on your treatment course

Why People Choose This

Powerful weight-loss and appetite regulation
Dual mechanism (GLP-1 + GIP) that supports insulin function and fat metabolism
Practical: fewer cravings, steadier energy, improved dietary control
Flexible titration to fine-tune results and tolerability
Includes: Enrollment in the 90-Day Metabolic Health program

How it Works

Tirzepatide activates both GLP-1 and GIP receptors. This dual action can enhance satiety, regulate blood sugar, and support fat metabolism—helping many patients experience robust, sustained results with stable energy.

Read the research →

How to Take & Store

Start dose: ~2.5 mg once weekly for 4 weeks.
Step-up path (typical): ~2.5 → 5 → 10 → 20 mg (pharmacy dependent).
Go slower if needed: Half-steps are reasonable to reduce side effects.
Sweet spot: Many patients find a dose that “clicks” and stay for months until they plateau; not everyone needs 20 mg.
Consistency matters: Keep weekly injections within 7–10 days; avoid splitting doses.
Storage: Refrigerate; follow your pharmacy’s insert for room-temp allowances.

BMI eligibility: Full dosing for BMI ≥27. For BMI 25–27, dosing is typically limited to ~2.5–7.5 mg. Maintenance at BMI 22–24 may be appropriate—discuss with your clinician.

How the Program Works

1

Select your treatment and check out (7-day authorization hold pending clinical review).

2

Complete your intake in the Patient Portal.

3

A licensed clinician reviews and may schedule a brief telehealth consult.

4

Upon approval, your charge and prescription are processed.

5

Shipping typically arrives in 1–3 business days.

6

Follow your plan in the Portal; message the Care Team anytime.

Telemedicine consult required — you’ll be redirected to our secure Patient Portal to complete your medical intake.

What to Expect

Month 1: weight loss can be 0–5 lb while the medicine “kicks in” (2–3 weeks); expect declining cravings and food noise.
Months 2–3: progressive appetite control and metabolic benefits; continue collaborative titration.

FAQs

Do I need a telemedicine consult?

Yes—completed in the Patient Portal after purchase.

Is this available in my state?

Currently California only; checkout will flag ineligible states.

How does dosing relate to “units”?

Units = volume; dose = mg. Vial concentrations (mg/mL) vary. Share vial/prescription photos so we confirm your mg dose precisely.

Side effects—what’s common?

Nausea, constipation/diarrhea, decreased appetite, heartburn, bloating/“sulfur burps,” headache, fatigue. Hydration, smaller meals, and labeled OTC options may help; consult your clinician.

Who should not take GLP-1/GIP meds?

Pregnancy/breastfeeding; certain diabetes regimens; personal/family history of medullary thyroid cancer or MEN syndromes; discuss all meds due to slowed absorption (e.g., warfarin, oral contraceptives, digoxin, statins, ACE-inhibitors).

Plateau strategy?

If progress stalls at higher doses, a clinician-guided switch between GLP-1s (e.g., semaglutide ↔ tirzepatide) can help.

Restarting after a break?

2 weeks: speak with your clinician. >30 days: typically restart at the beginning dose.

Not for use if pregnant or breastfeeding. If you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2, this therapy may not be safe for you. Stop medication and contact your clinician for severe abdominal pain or persistent vomiting.

This information is educational and does not constitute medical advice. A licensed clinician will determine if this therapy is appropriate for you. See Full Safety Info and Terms.